These results suggest a similar effect of increased KLF4 levels to what has previously been observed in multiple myeloma, in which higher KLF4 levels reduce proliferation in-vitro, but produce tumors that are associated with decreased patient survival in-vivo due to increased resistance to apoptosis by alkylating chemotherapy agents21. The gene discussed is KLF4; the disease is AL amyloidosis.